Liposomes modified with polycation used for gene delivery:: Preparation, characterization and transfection in vitro

被引:46
作者
Chen, Jin-Liang
Wang, Hua
Gao, Jian-Qing
Chen, Hai-Liang
Liang, Wen-Quan [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Peoples R China
[2] Zhejiang Univ, Ctr Anal & Measurement, Hangzhou 310029, Peoples R China
基金
中国国家自然科学基金;
关键词
polycation; liposomes; gene delivery vector;
D O I
10.1016/j.ijpharm.2007.05.045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene therapy provides great opportunities for treating diseases from genetic disorders, infections and cancer. The development of efficient and safe gene transfer systems could be one of the most important factors for successful gene therapy. In the present study, an amphiphilic compound, polyethylenimine (PEI, MW 800)-cholesterol (PEI 800-Chol), firstly designed to modify the surface of liposomes, was synthesized. Polycation liposomes (PCLs) composed of soybean phospholipids (SPL), cholesterol (Chol) and PEI 800-Chol were prepared using film hydration method. The mean particle size of the PCLs was 133.0 nm and the zeta potential was 50.1 +/- 2.6 mV. Due to the PEI anchored onto the surface of liposomes, higher buffering capacity of PCLs was observed, indicating the potential for buffering in the acidic pH environment of the endosomes. Compared to Lipofectamine (TM) 2000, PCLs have equivalent transfection efficiency with significantly low cytotoxicity. Interestingly, the transfection activity of PCLs was not influenced in the presence of serum. Furthermore, we constructed another PCL composed of PEI 800-Chol and DOPE, and transfection efficiency increased notably. In conclusion, the PCLs described in this study have high transfection efficiency with low cytotoxicity, as well as the protection ability from serum, which suggests PCLs would be a potential non-viral gene delivery system. (C) 2007 Published by Elsevier B.V.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 31 条
[1]   Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis [J].
Akinc, A ;
Thomas, M ;
Klibanov, AM ;
Langer, R .
JOURNAL OF GENE MEDICINE, 2005, 7 (05) :657-663
[2]   Cationic liposome-mediated gene delivery: Biophysical study and mechanism of internalization [J].
Almofti, MR ;
Harashima, H ;
Shinohara, Y ;
Almofti, A ;
Baba, Y ;
Kiwada, H .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 410 (02) :246-253
[3]   Improvement of gene transfer to cervical cancer cell lines using non-viral agents [J].
Cho, CW ;
Cho, YS ;
Kang, BT ;
Hwang, JS ;
Park, SN ;
Yoon, DY .
CANCER LETTERS, 2001, 162 (01) :75-85
[4]   DOTAP/DOPE and DC-Chol/DOPE lipoplexes for gene delivery: zeta potential measurements and electron spin resonance spectra [J].
Ciani, L ;
Ristori, S ;
Calamai, L ;
Martini, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1664 (01) :70-79
[5]   Studying biophysical barriers to DNA delivery by advanced light microscopy [J].
De Smedt, SC ;
Remaut, K ;
Lucas, B ;
Braeckmans, K ;
Sanders, NN ;
Demeester, J .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (01) :191-210
[6]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[7]   An overview of current delivery systems in cancer gene therapy [J].
El-Aneed, A .
JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) :1-14
[8]   Potentiation of cationic liposome-mediated gene delivery by polycations [J].
Gao, X ;
Huang, L .
BIOCHEMISTRY, 1996, 35 (03) :1027-1036
[9]   Serum-resistant lipopolyplexes for gene delivery to liver tumour cells [J].
Garcia, Leire ;
Bunuales, Maria ;
Duzgunes, Nejat ;
de Ilarduya, Conchita Tros .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (01) :58-66
[10]   Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery [J].
Godbey, WT ;
Wu, KK ;
Mikos, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5177-5181